Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update

Go back to Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update
(NASDAQ: IOVA) Delayed: 4.44 +0.38 (9.36%)
Previous Close $4.06    52 Week High
Open $4.00    52 Week Low
Day High $4.52    P/E N/A 
Day Low $3.99    EPS
Volume 17,961,813